The Journal of Physical Chemistry A
Article
in one portion, after which the mixture was heated to reflux and
stirred for 6 h. After cooling to room temperature, the reaction
mixture was filtered and the solid was washed with acetone.
The filtrate was concentrated in vacuo to afford a dark solid,
which was treated with CH2Cl2 and washed with a pH 10
carbonate buffer solution. The precipitated zinc salts were
filtered off and the filtrate was washed with brine. The resulting
organic layer was dried over anhydrous magnesium sulfate,
filtered, and concentrated to afford a dark oil. The crude
product was purified by flash chromatography using hexane/
EtOAc as the mobile phase on a 120 g SiO21column. The pure
product was isolated in 66% yield (1.4 g). H NMR (CDCl3,
600 MHz) δ 7.46−7.33 (m, 10H, CHAr), 6.69 (d, 1H, J = 8.4
Hz, CHAr), 6.65 (d, 1H, J = 2.5 Hz, CHAr), 6.49 (dd, 1H, J =
8.4, 2.5 Hz, CHAr), 5.06 (s, 2H, CH2), 5.00 (s, 2H, CH2), 3.60
(br, 2H, NH2). 13C{1H} NMR (CDCl3, 151 MHz) δ 152.2,
147.4, 137.5, 137.0, 130.5, 128.7, 128.6, 128.1, 127.9, 127.7,
127.6 115.4, 106.4, 101.9, 70.9, 70.6. HRMS (ESI): m/z calcd
for [C20H20NO2]+ 306.14940; found 306.14831.
Synthesis of 2,4-Bis(benzyloxy)-N-(4-nitrophenyl)-
aniline (9). To an oven-dried round-bottom flask equipped
with a magnetic stir bar, a reflux condenser, and a N2 inlet was
charged Pd(OAc)2 (140 mg, 0.624 mmol, 5 mol %), Ph3P (491
mg, 1.87 mmol, 15 mol %), Cs2CO3 (12.21 g, 37.47 mmol),
and 1-bromo-4-nitrobenzene (2.523 g, 12.49 mmol). The flask
was evacuated and refilled with N2 three times prior to the
addition of 8 (4.00 g, 13.1 mmol) in dry toluene (125 mL).
The mixture was heated to reflux using an oil bath and stirred at
reflux. After 24 h, the reaction mixture was cooled to room
temperature and filtered through a pad of SiO2. The solid was
washed with EtOAc, and the combined filtrate was concen-
trated in vacuo to yield an oil. The crude product was
crystallized by dissolving in minimal CH2Cl2 followed by the
addition of hexane. The desired product was isolated as an
orange solid (4.2 g, 79% yield). 1H NMR (CDCl3, 600 MHz) δ
8.07 (d, 2H, J = 9.2 Hz, CHAr), 7.42−7.24 (m, 11H, CHAr),
6.81 (d, 2H, J = 9.2 Hz, CHAr), 6.70 (d, 1H, J = 2.7 Hz, CHAr),
6.59 (dd, 1H, J = 8.7, 2.7 Hz, CHAr), 6.18 (br, 1H, NH), 5.04
(s, 2H, CH2), 5.03 (s, 2H, CH2). 13C{1H} NMR (CDCl3, 151
MHz) δ 156.9, 152.4, 151.4, 139.3, 136.8, 136.2, 128.8, 128.4,
128.3, 127.7, 127.6, 126.3, 123.8, 122.5, 113.3, 106.0, 102.2,
70.9, 70.6. HRMS (ESI): calcd for [C26H22N2O4Na]+
449.14773; found 449.14677.
Synthesis of 4-((4-Aminophenyl)amino)benzene-1,3-
diol (3). To a Fisher-Porter bottle with a magnetic stir bar was
added 9 (500 mg, 1.17 mmol), methanol (10 mL), and 10% wt
Pd on activated carbon (70 mg). The vessel was sealed and
purged seven times with H2 before the H2 pressure was set to
75 psig. The reaction mixture was stirred at room temperature
for 12 h, after which H2 was vented and the bottle was refilled
with N2. The vessel was taken into a drybox, and the contents
were filtered through a pad of dried Celite, which was rinsed
with ethanol. The combined filtrate was concentrated in vacuo
to afford 240 mg (95% yield) of dark solid. The solid was
transferred to a vial and stored under vacuum. 1H NMR
(DMSO, 600 MHz) δ 9.14 (br, 1H, OH), 8.75 (br, 1H, OH),
6.71 (d, J = 8.5 Hz, 1H, CHAr), 6.66 (d, J = 8.8 Hz, 2H, CHAr),
6.43 (d, J = 8.8 Hz, 2H, CHAr), 6.31 (d, J = 2.7 Hz, 1H, CHAr),
6.09 (dd, J = 8.5, 2.7 Hz, 1H, CHAr), 6.01 (br, 1H, NH) 4.39
(br, 2H, NH2). 13C{1H} NMR (DMSO, 151 MHz) δ 151.8,
148.9, 141.6, 135.7, 124.8, 119.3, 118.4, 113.8, 105.5, 103.1. MS
(ES+, m/z): 217.21 ([M + 1]+, 100%).
Oxidative Oligomerization Following Hydrogenolysis
of 9. Compound 9 (60.8 mg, 143 μmol), 10% wt Pd on
activated carbon (70 mg), and ethanol (10 mL) were added to
a Fisher-Porter bottle. The vessel was sealed and flushed with
H2 seven times before the H2 pressure was set to 70 psig. The
mixture was stirred under H2 for 12 h, after which H2 was
vented and the vessel was backfilled with N2. The mixture was
filtered (using a 0.45 μm glass syringe filter) into a flask
containing 5 mL of ethanol. O2 was bubbled through the
solution until the solvent had evaporated, resulting in the
isolation of 50 mg of dark solid. MS (ESI, m/z): 321.20
(C18H17N4O2, [M + H]+ of 5), 429.19 (C24H21N4O4), 643.31
(C36H31N6O6), 855.27 (C48H39N8O8).
Resorufamine Generated from 9. Compound 9 (61.6
mg, 145 μmol), 10% wt Pd on activated carbon (70 mg), and
ethanol (10 mL) were added to a Fisher-Porter bottle. The
vessel was sealed and flushed with H2 seven times before the H2
pressure was set to 70 psig. After stirring at this pressure for 10
h, the excess hydrogen was vented, and the colorless solution
was filtered into a pH 10.4 aq solution containing K3Fe(CN)6
(119 mg, 361 μmol). The resulting mixture was stirred for 30
min before filtering through a 0.45 μm glass filter. Removal of
the solvent from the filtrate afforded a dark solid, which was
treated with EtOH and filtered again. The filtrate was
concentrated under vacuum, and the resulting pink solid was
dissolved in 1 M HCl and purified by preparative HPLC
(reversed-phase C18-capped silica, MeCN−water as the mobile
1
phase) to afford 15 mg (49% yield) of dark solid. H NMR
(DMSO, 600 MHz) δ 7.50 (d, J = 8.8 Hz, 1H, CH), 7.43 (d, J
= 9.6 Hz, 1H, CHAr), 7.02 (s, 2H, NH2), 6.71 (dd, J = 8.8, 2.4
Hz, 1H, CH), 6.62 (dd, J = 9.7, 2.1 Hz, 1H, CHAr), 6.49 (d, J =
2.4 Hz, 1H, CH), 6.16 (d, J = 2.1 Hz, 1H, CHAr).
Initial Rate Study of the Oxidation of 5 by K3Fe(CN)6
To Generate 10. To a 25 mL volumetric flask was added 5
(9.2 mg, 28.7 μmol), which was diluted to the line with pH 10.4
buffer and sonicated in a 30 °C bath for 5 min. An aliquot (435
μL) was taken from stock solution and diluted with phosphate
buffer to 10 mL in a volumetric flask so that the final
concentration was 50 μM. The final solution was loaded into a
10 mL disposable syringe and placed at stopped-flow injection
slot A. The buffer solution was loaded into another disposable
10 mL syringe and placed at injection slot B. A background
scan was collected by injecting 0.25 mL of each syringe driven
by a pneumatic piston. The final solution of 5 in the
observation cell was 25 μM. This spectrum of 5 was used as
the absorbance baseline so that kinetic run would record the
change in absorbance relative to 5. To a 5 mL volumetric flask
was added K3Fe(CN)6 (21.9 mg, 66.5 μmol), which was diluted
to the line with pH 10.4 buffer and sonicated in a 30 °C bath
for 5 min. An aliquot (75.1 μL) was taken from the stock
solution and diluted with phosphate buffer to 10 mL in a
volumetric flask so that the final concentration was 100 μM.
The solution was loaded into a syringe and replaced the buffer
syringe located in injection slot B. The Julabo water circulator
was set to 25 °C, and the solutions were kept in the loading
syringes for 5 min to allow for temperature equilibration. The
kinetic runs occurred by injecting 0.25 mL of each syringe
through the observation cell bringing the final concentrations of
the reagents as follows: [5] = 25 μM and [K3Fe(CN)6] = 50
μM. The rate was determined by observing the change in
absorbance at 532 nm (used due to greatest observable change
in absorbance from 5 to 10 without interference of the
ferricyanide absorbance). Product concentration was calculated
C
J. Phys. Chem. A XXXX, XXX, XXX−XXX